Primary hepatoid adenocarcinoma of the lung in Yungui Plateau, China: A case report

Table 1 Clinicopathologic characteristics of patient with hepatoid adenocarcinoma of the lung

Ref.	Year	Region	Age / Sex	Maximum diameter in cm	Ki-67	VEGF	Immunohistochemical AFP	Serum AFP as μg/L	Hepatocyte	Survival time
Bai et al[9]	2006	Shanghai	48/M	7	Low-medium level	no data	-	-	+	9 mo
Cao et al[12]	2008	Beijing	64/M	3	no data	no data	no data	2037	no data	12 mo
Feng et al[13]	2013	Shanghai	46/M	2.4	no data	no data	little +	586	little +	6 mo
Haninger et al[14]	2013	Louisville	51/M		lowly proliferative	no data				14 mo
Shaib et al[15]	2014	Atlanta	53/F		no data	no data				4 yr
Gavrancic et al [16]	2014	New York	64/M		no data	no data				2 mo
Che et al[17]	2014	Beijing	48/M		no data	no data
Liu et al[18]	2014	Guangzhou	64/M		no data	no data
Zhong et al[19]	2015	Jiangxi	61/M	5.7	40% +	no data	++	943	-	2 wk
Motooka et al[20]	2016	Kumamoto	69/M	4.3	no data	no data	+	4497	+	51 mo
Sun et al[21]	2016	Shandong	59/M		20%	no data				23 mo
Grossman et al[22]	2016	New York	54/M		no data	no data				3 mo
Hou et al[11]	2017	Shandong	59/M	4	20%	no data	-	-	no data	12 mo
YF Shi	2018	Yunnan	60/M	7	50% +	no data	no data	1210	weak+	15 mo

VEGF: Vascular endothelial growth factor; AFP: α-Fetoprotein; Ki-67: Nuclear-associated antigen 67.